Ivermectin Trial Designed To Get It Banned Just Like Hydroxychloroquine?
461 Views
16
People died in the so called trial just to show that HCQ is dangerous?
The Problem With Hydroxychloroquine
The leading scientific advocates of hydroxychloroquine recommend that it should primarily be used in the early stages of COVID-19, or even prior to developing the syndrome, as a prophylactic. Should the person develop the symptoms of COVID-19, they could, for example, begin a course of what has become known as the Marseilles Treatment: hydroxychloroquine with the antibiotic azithromycin (HCQ AZ) plus zinc to aid absorption.
Struggling to comprehend the seemingly inexplicable resistance to trialling HCQ AZ, Prof. Harvey Risch, MD, from Yale University, argued that HCQ AZ should immediately be used as an early therapy for COVID-19 patients. He wrote:
Hydroxychloroquine azithromycin has been widely misrepresented in both clinical reports and public media…..Five studies, including two controlled clinical trials, have demonstrated significant major outpatient treatment efficacy......These medications need to be widely available and promoted immediately for physicians to prescribe.
His is far from the only eminently qualified opinion questioning the irrational blocking of treatment with hydroxychloroquine. In Michigan, the Association of American Physicians and Surgeons (AAPS) have launched an appeal against an FDA injunction to allow them to prescribe hydroxychloroquine for their COVID-19 patients.
Read more: https://www.ukcolumn.org/article/the-hydroxychloroquine-scandal
Ivermectin Trial Designed To Get It Banned Just Like Hydroxychloroquine?
The Problem With Hydroxychloroquine
The leading scientific advocates of hydroxychloroquine recommend that it should primarily be used in the early stages of COVID-19, or even prior to developing the syndrome, as a prophylactic. Should the person develop the symptoms of COVID-19, they could, for example, begin a course of what has become known as the Marseilles Treatment: hydroxychloroquine with the antibiotic azithromycin (HCQ AZ) plus zinc to aid absorption.
Struggling to comprehend the seemingly inexplicable resistance to trialling HCQ AZ, Prof. Harvey Risch, MD, from Yale University, argued that HCQ AZ should immediately be used as an early therapy for COVID-19 patients. He wrote:
Hydroxychloroquine azithromycin has been widely misrepresented in both clinical reports and public media…..Five studies, including two controlled clinical trials, have demonstrated significant major outpatient treatment efficacy......These medications need to be widely available and promoted immediately for physicians to prescribe.
His is far from the only eminently qualified opinion questioning the irrational blocking of treatment with hydroxychloroquine. In Michigan, the Association of American Physicians and Surgeons (AAPS) have launched an appeal against an FDA injunction to allow them to prescribe hydroxychloroquine for their COVID-19 patients.
Read more: https://www.ukcolumn.org/article/the-hydroxychloroquine-scandal
Ivermectin Trial Designed To Get It Banned Just Like Hydroxychloroquine?